The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHend.eur.focus Regulatory News (HEFT)

Share Price Information for Hend.eur.focus (HEFT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 181.00
Bid: 180.00
Ask: 181.50
Change: 1.00 (0.56%)
Spread: 1.50 (0.833%)
Open: 180.00
High: 181.00
Low: 179.50
Prev. Close: 180.00
HEFT Live PriceLast checked at -
Henderson European Focus Trust is an Investment Trust

seeks to maximise total return from a focused portfolio of listed stocks, mainly in Continental Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

28 May 2020 16:10

RNS Number : 2695O
Henderson European Focus Trust PLC
28 May 2020
 

Legal Entity Identifier: 213800GS89AL1DK3IN50

 

HENDERSON EUROPEAN FOCUS TRUST PLC

 

Unaudited results for the half-year ended 31 March 2020

 

This announcement contains regulated information

 

Investment Objective

The Company seeks to maximise total return (a combination of income and capital growth) from a portfolio of stocks listed in Europe.

 

Performance for the half-year ended 31 March 2020

• Net asset value ("NAV") total return1 of -15.5% compared to the benchmark2 return of -16.7%

• Share price3 total return of -19.2%

• Interim dividend of 9.60p per share declared (2019: 9.60p)

 

Total return performance to 31 March 2020 (with dividends reinvested)

 

6 months

%

1 year

%

3 years

%

5 years

%

10 years

 %

NAV1

-15.5

-5.6

-2.9

21.6

120.8

Benchmark index2

-16.7

-8.0

-1.6

20.6

70.8

Average AIC sector NAV4

-15.9

-7.7

1.9

25.3

113.6

Share price3

-19.2

-9.8

-18.4

1.3

103.8

Average AIC sector share price4

-17.0

-9.0

-2.0

14.3

116.9

 

1 Net asset value ("NAV") total return per ordinary share (with dividends reinvested)

2 FTSE World Europe ex UK Index on a total return basis in Sterling terms

3 Share price total return (with dividends reinvested) using mid-market closing price

4 Association of Investment Companies ("AIC") Europe sector

 

Sources: Morningstar for the AIC, Refinitiv Datastream and Janus Henderson

 

 

Financial highlights

 

At 31 March 2020

At 30 September 2019

Shareholders' funds

 

 

Net assets (£'000)

249,015

299,010

Net asset value ("NAV") per ordinary share

1,158.30p

1,390.86p

Mid-market share price per ordinary share

990.00p

1,245.00p

Gearing at period end

2.1%

 4.6%

 

 

 

 

Half-year ended

31 March 2020

Year ended

30 September 2019

Total return to equity shareholders

 

 

Revenue return after taxation (£'000)

Capital (loss)/return after taxation (£'000)

1,084

5,767

(46,414)

6,139

Total (loss)/return

(45,330)

11,906

Total return per ordinary share

 

 

Revenue

5.04p

26.83p

Capital

(215.90p)

28.55p

Total return

(210.86p)

55.38p

 

 

 

INTERIM MANAGEMENT REPORT

 

Chairman's Statement

 

When I took over as your Chairman immediately following the Annual General Meeting in January 2020 no one could have imagined the rapid spread of COVID-19 across the globe nor the impact it would have on the investment world. Global stock markets crashed in a way not seen since the financial crisis of 2008 with the consequent impact on your Company's share price, exacerbated by a widening of the discount to net asset value ("NAV") at which your Company's shares trade. It is at times like these that it pays to have an experienced investor from a major investment firm managing the portfolio who did not panic but focused on maintaining the quality of the portfolio by investing in companies with proper funding and robust balance sheets, cash-generative businesses and low leverage. Whilst the full impact of this crisis is not yet clear, your Company is well positioned to outperform through the recovery.

 

Performance

In the six months to 31 March 2020, the Company's NAV total return per ordinary share fell by 15.5%, compared to a fall of 16.7% in the Company's benchmark, the FTSE World Europe ex UK index, resulting in outperformance of the benchmark of 1.2%. The Company's share price fell by 19.2% to 990 pence, ending the period at a wider than normal 14.5% discount to NAV (30 September 2019: 10.5% discount). Gearing has been actively managed and was 2.1% of net assets at the period end. As at 26 May 2020, the share price had increased by 16.7% to 1155 pence, the discount had narrowed to 12.4% and gearing was 1.4% of net assets.

 

Revenue and dividend

As I expect you are very well aware the majority of companies are reviewing their dividends in the light of the COVID-19 situation. This may have a significant impact on the revenue generated from the portfolio. We are, however, well placed through our revenue reserves to smooth dividend payments should this be required. That said, it will be important to assess the likely longer-term revenue impact of this crisis.

 

In the light of these circumstances the Board has decided to declare a maintained interim dividend of 9.60 pence per ordinary share (2019: 9.60 pence). This will be paid on 26 June 2020 to shareholders on the register on 5 June 2020. The shares will be quoted ex-dividend on 4 June 2020. The Board will consider what final dividend to propose at the end of the year in the light of the relevant evidence available at that time.

 

Board and Fund Manager

Rodney Dennis, Alec Comba and Alain Dromer all retired as directors at the 2020 AGM. Rodney and Alec joined the Board together in November 2003, Rodney became Chairman in September 2006 and Alec was for many years Chairman of the Audit Committee and more recently Senior Independent Director. They steered your Company through some challenging times and each made a significant contribution to the development of the Company. Alain joined the Board in 2014 and was always generous in sharing his knowledge and experience. Our thanks and best wishes go to them all.

 

I am pleased to announce that Vicky Hastings has been appointed Senior Independent Director.

 

In January 2020, we were pleased to welcome Tom O'Hara as Co-Fund Manager of the portfolio alongside our lead Fund Manager John Bennett.

 

Outlook

Due to the COVID-19 situation we are now experiencing a period that for many of us will be the most challenging and uncertain that we have ever faced. The emergence of the pandemic has significantly increased many of the operational as well as the market risks to the Company's business. I would like to reassure shareholders that all operational aspects of your Company have continued to operate smoothly despite the necessary move to remote working by the Manager, the Fund Managers, other key third parties and indeed the Board itself. We have kept and will remain closely in touch with the key parties to ensure that this remains the case.

 

The outlook for European, and indeed global, economies is uncertain as the full consequences of the actions taken to fight the COVID-19 pandemic are not yet known. Europe is moving into a deep recession which will hopefully be brief but is presently of unknown duration. Whilst the fiscal and monetary responses from central authorities across the world have been dramatic the level of global cooperation to address a pandemic that respects no national boundaries has been weak. Against this background I consider that our Fund Managers' focus on cash generative companies with strong balance sheets and low leverage should serve shareholders well.

 

 

Robert Jeens

Chairman

28 May 2020

 

 

 

Fund Managers' Report

 

It hardly needs saying that the overwhelming factor for all of us during the period under review and, indeed, at the time of writing, has been the global pandemic known as COVID-19. As this virus has spread west, so has its effect on financial markets. Here in Europe, the month of March 2020 saw quite astonishing levels of volatility and severe strain within the financial system. For example, the EuroStoxx 50 index sold off by 30% to begin the month, before rebounding by 19% from trough to peak. As ever, headline indices rarely tell the full story and we have seen wild swings at the individual stock level, often intra-day. Not for the first time, extreme volatility has been aggravated by forced liquidation of excess leverage: leveraged corporates, leveraged funds, whether managed by computer or by human, have found themselves in the crosshairs.

 

The banking system, courtesy of much tougher regulation since the global financial crisis, seems better prepared than usual. That preparation now includes the forced 'postponement' or cancellation of dividends. Shareholders in banks are now relegated further down the pecking order, more than a decade after what many saw as the great bailout of 'greedy bankers' at the expense of the wider workforce. It is the latter that governments are desperate to be seen to protect this time around. Governments have decided that it is time to try - the emphasis is on try - to favour one factor of production over another: labour over capital. They know they will be judged on this, as well as on protecting the health of their voters. The era of big government has truly arrived. We would remind investors that we sold out of the banking sector, a large component of most European indices, in early 2019. A prime reason for that decision was that we saw the industry headed inexorably toward regulated social utility status: recent events have probably guaranteed that.

 

The extraordinary monetary and fiscal stimulus unleashed worldwide should provide the necessary credit and liquidity to get through this recession. While this cannot reduce the severity of the economic crash in the very near term, it is at least hoped that it shortens its duration.

 

Portfolio

We often remind ourselves of the saying "if you're going to panic, panic early". We have felt no urge to panic during this crash. Instead, we have seen fit to utilise the Company's flexibility to accommodate gearing. During the savage sell-off in March 2020 we tactically increased portfolio gearing to some 10%. Subsequently, in the strong rally of the second half of March, we restored gearing to a negligible level of 2.1%. It is fair to say that we rarely get tactical in this fashion but were prepared to do so in such market conditions.

 

Whilst we are now starting to see some lockdown restrictions easing, we are expecting to see a very different backdrop and level of economic activity over at least the next 6 to 12 months to the ones we have been used to. We have been reviewing the Company's holdings, and in particular their balance sheets, to assess whether they would be able to survive several months of shutdown, whether they have had to access COVID 19-related state support and the resultant recessionary phase which could follow, reassessing how companies are likely to fare in these uncertain times and whether they will come out of the current crisis stronger. Our focus remains on looking beyond the news headlines and focusing instead on individual businesses and their fundamentals.

 

Away from tactics, it is at times such as this that our innate preference for well capitalised, cash generative businesses comes to the fore. Any business entering this crisis in an over-leveraged state finds itself much weakened, some terminally so. As with all crises, the situation will pass, recovery will take hold and it is those businesses, with strong market shares, talented management teams and strong balance sheets, who will emerge as the winners. It is our belief that your Company is a portfolio of just such businesses.

 

 

John Bennett and Tom O'Hara

Fund Managers

28 May 2020

 

 

 

Principal Investments as at 31 March 2020

Company

Sector

Country of listing

Valuation £'000

% of

portfolio

LafargeHolcim

Construction & Materials

Switzerland

18,722

7.4

Nestlé

Food Producers

Switzerland

13,616

5.3

UPM-Kymmene

Forestry & Paper

Finland

10,421

4.1

Roche

Pharmaceuticals & Biotechnology

Switzerland

10,171

4.0

ASML

Technology Hardware & Equipment

Netherlands

9,667

3.8

SAP

Software & Computer Services

Germany

9,213

3.6

Novartis

Pharmaceuticals & Biotechnology

Switzerland

7,812

3.1

Grifols

Pharmaceuticals & Biotechnology

Spain

7,496

3.0

Philips

Health Care Equipment & Services

Netherlands

7,236

2.9

TELE2

Mobile Telecommunications

Sweden

6,953

2.7

 

 

 

-----------

------------

10 largest

 

 

101,307

39.9

 

 

 

-----------

------------

AKZO Nobel

Chemicals

Netherlands

6,907

2.7

Novo-Nordisk

Pharmaceuticals & Biotechnology

Denmark

6,663

2.6

Tessenderlo

Chemicals

Belgium

6,444

2.5

Adidas

Personal Goods

Germany

5,739

2.3

STMicroelectronics

Technology Hardware & Equipment

France

5,738

2.3

Carlsberg

Beverages

Denmark

5,517

2.2

Autoliv

Automobiles & Parts

Sweden

5,503

2.2

ASR Nederland

Nonlife Insurance

Netherlands

5,341

2.1

Enel

Electricity

Italy

5,326

2.1

Kion

Industrial Engineering

Germany

5,178

2.0

 

 

 

-----------

------------

20 largest

 

 

159,663

62.9

 

 

 

-----------

------------

Sandvik

Industrial Engineering

Sweden

5,162

2.0

Kone

Industrial Engineering

Finland

5,006

2.0

Volvo

Industrial Transportation

Sweden

4,761

1.9

Sanofi

Pharmaceuticals & Biotechnology

France

4,732

1.9

Deutsche Boerse

Financial Services

Germany

4,659

1.8

Bayer

Pharmaceuticals & Biotechnology

Germany

4,636

1.8

LVMH Moet Hennessy Louis Vuitton

Personal Goods

France

4,377

1.7

SBMOffshore

Oil Equipment Services & Distribution

Netherlands

4,323

1.7

Merck

Pharmaceuticals & Biotechnology

Germany

4,320

1.7

Energias de Portugal

Electricity

Portugal

4,309

1.7

 

 

 

------------

------------

30 largest

 

 

205,948

81.1

 

 

 

------------

------------

Other listed investments (15 stocks)

 

48,212

18.9

 

 

------------

------------

Total investments at fair value

 

254,160

100.0

 

 

=======

=======

 

 

Country of listing (as a percentage of the portfolio excluding cash)

 

 

31 March 2020

%

31 March 2019

%

Switzerland

19.8

18.1

Germany

18.4

16.6

Netherlands

14.3

11.4

Sweden

11.3

12.3

France

9.1

7.6

Finland

7.7

7.7

Denmark

4.8

5.4

Spain

4.2

3.8

Italy

3.4

2.5

Belgium

2.6

3.0

Portugal

1.7

3.2

Norway

1.4

2.3

United Kingdom

1.3

6.1

 

100.0

100.0

 

 

Sector exposure (as a percentage of the portfolio excluding cash)

 

 

31 March 2020

%

31 March 2019

%

Industrials

21.0

15.1

Consumer goods

20.9

28.2

Health care

20.9

20.5

Technology

12.1

9.8

Basic materials

10.5

8.6

Financials

5.2

7.2

Utilities

5.0

-

Telecommunications

2.7

2.2

Oil & gas

1.7

6.9

Consumer services

-

1.5

 

100.0

100.0

 

 

 

Principal Risks and Uncertainties

 

The principal risks and uncertainties associated with the Company's business can be divided into the following main areas:

 

· Market

· Investment performance

· Business strategy and market rating

· Gearing

· Operational

· Regulatory and reporting

 

Information on these risks and how they are managed is given in the Annual Report to 30 September 2019. In the view of the Board, these principal risks and uncertainties at the year-end remain and are as applicable to the remaining six months of the financial year as they were to the six months under review.

 

There are a number of risks stemming from the COVID-19 pandemic and the uncertainty that this has created in global markets, both economically and politically, that may impact the operation of the Company, as referenced in the Chairman's Statement. The Fund Managers will continue to review carefully the composition of the Company's portfolio and be proactive in taking investment decisions where necessary.  Janus Henderson (the "Manager") and the Company's other third-party service providers remain fully operational and have implemented appropriate business continuity plans to ensure that there has been no change in service while the majority of staff are working from home.

 

 

 

Related Party Transactions

 

The Company's transactions with related parties in the period were with the directors and the Manager. There have been no material transactions between the Company and its directors during the period other than amounts paid to them in respect of expenses and remuneration for which there were no outstanding amounts payable at the period end.

 

In relation to the provision of services by the Manager, other than fees payable by the Company in the ordinary course of business and the facilitation of marketing activities with third parties, there have been no transactions with the Manager affecting the financial position of the Company during the period under review.

 

 

 

Statement of Directors' Responsibilities

 

The directors confirm that, to the best of their knowledge:

 

(a) the condensed financial statements for the half-year to 31 March 2020 have been prepared in accordance with FRS 104 Interim Financial Reporting, and gives a true and fair view of the assets, liabilities, financial position and profit or loss of the Company;

 

(b) the Interim Management Report and condensed financial statements include a fair review of the information required by Disclosure Guidance and Transparency Rule 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and

 

(c) the Interim Management Report includes a fair review of the information required by the Disclosure Guidance and Transparency Rule 4.2.8R (disclosure of related-party transactions and changes therein).

 

 

For and on behalf of the Board

Robert Jeens

Chairman

28 May 2020

 

 

 

CONDENSED Income Statement

 

 

 

(Unaudited)

Half-year ended

31 March 2020

(Unaudited)

Half-year ended

31 March 2019

(Audited)

Year ended

30 September 2019

 

Revenue return £'000

Capital return £'000

Total return £'000

Revenue return £'000

Capital return £'000

Total return £'000

Revenue return £'000

Capital return £'000

Total

 return

£'000

 

 

 

 

 

 

 

 

 

 

(Losses)/gains on investments held at fair value through profit or loss

-

(45,235)

(45,235)

-

(20,217)

(20,217)

-

8,166

8,166

 

 

 

 

 

 

 

 

 

 

Exchange (loss)/gain on currency transactions

-

(377)

(377)

-

324

324

-

(278)

(278)

 

 

 

 

 

 

 

 

 

 

Income from investments (note 2)

1,819

-

1,819

2,122

-

2,122

7,550

-

7,550

 

 

 

 

 

 

 

 

 

 

Other income

11

-

11

2

-

2

14

-

14

Gross revenue and capital (losses)/gains

1,830

(45,612)

(43,782)

2,124

(19,893)

(17,769)

7,564

7,888

15,452

 

 

 

 

 

 

 

 

 

 

Management fees (note 6)

(226)

(679)

(905)

(213)

(640)

(853)

(454)

(1,362)

(1,816)

Other fees and expenses

(256)

-

(256)

(279)

-

(279)

(542)

-

(542)

Net return/(loss) before finance costs and taxation

1,348

(46,291)

(44,943)

1,632

(20,533)

(18,901)

6,568

6,526

13,094

 

 

 

 

 

 

 

 

 

 

Finance costs

(47)

(123)

(170)

(60)

(181)

(241)

(124)

(309)

(433)

Net return/(loss) before taxation

1,301

(46,414)

(45,113)

1,572

(20,714)

(19,142)

6,444

6,217

12,661

 

 

 

 

 

 

 

 

 

 

Taxation on net return

(217)

-

(217)

(191)

-

(191)

(677)

(78)

(755)

Net return/(loss) after taxation

1,084

(46,414)

(45,330)

1,381

(20,714)

(19,333)

5,767

6,139

11,906

Return/(loss) per ordinary share (note 3)

5.04p

(215.90p)

(210.86p)

6.42p

(96.35p)

(89.93p)

26.83p

28.55p

55.38p

           

 

The total columns of this statement represent the Income Statement of the Company prepared in accordance with FRS 104.

 

The revenue return and capital return columns are supplementary to this and are prepared under guidance published by the Association of Investment Companies.

 

All revenue and capital items in the above statement derive from continuing operations. The Company had no recognised gains or losses other than those disclosed in the Income Statement and the Statement of Changes in Equity.

 

The accompanying notes are an integral part of the condensed financial statements.

 

 

 

CONDENSED Statement of Changes in Equity

Half-year ended 31 March 2020(Unaudited) Called-upshare

capital

£'000

 

Special

distributable

reserve

£'000

Share premium account £'000

 

 

 Merger reserve £'000
 Capital redemption reserve

£'000

 

 Capital reserve

£'000

Revenue reserve

£'000

Total

shareholders' funds

£'000

At 30 September 2019

10,819

25,846

41,995

61,344

9,421

138,013

11,572

299,010

Net (loss)/return after taxation

-

-

-

-

-

(46,414)

1,084

(45,330)

Ordinary dividend paid

-

-

-

-

-

-

(4,665)

(4,665)

At 31 March 2020

10,819

25,846

41,995

61,344

9,421

91,599

7,991

249,015

Half-year ended 31 March 2019(Unaudited)  Called-upshare

capital

£'000

 

 

Special

distributable

reserve

£'000

Share premium account £'000

 

 

 

 Merger reserve £'000
 Capital redemption reserve

£'000

 

 Capital reserve

£'000

Revenue reserve

£'000

Total

shareholders' funds

£'000

At 30 September 2018

10,819

25,846

41,995

61,344

9,421

131,874

12,491

293,790

Net (loss)/return after taxation

-

-

-

-

-

(20,714)

1,381

(19,333)

Ordinary dividend paid

-

-

-

-

-

-

(4,622)

(4,622)

At 31 March 2019

10,819

25,846

41,995

61,344

9,421

111,160

9,250

269,835

Year ended 30 September 2019(Audited)  Called-upshare

capital

£'000

 

 

Special

distributable

reserve

£'000

Share premium account £'000

 

 

 

 Merger reserve £'000
 Capital redemption reserve

£'000

 

 Capital reserve

£'000

Revenue reserve

£'000

Total

shareholders' funds

£'000

At 30 September 2018

10,819

25,846

41,995

61,344

9,421

131,874

12,491

293,790

Net return after taxation

-

-

-

-

-

6,139

5,767

11,906

Ordinary dividend paid

-

-

-

-

-

-

(6,686)

(6,686)

At 30 September 2019

10,819

25,846

41,995

61,344

9,421

138,013

11,572

299,010

 

The accompanying notes are an integral part of the condensed financial statements.

 

 

 

CONDENSED Statement of Financial Position

 

 

(Unaudited)

31 March

2020

£'000

(Unaudited)

31 March

2019

£'000

(Audited)

30 September

2019

£'000

Fixed assets

 

 

 

Investments held at fair value through profit or loss

254,160

271,837

312,880

 

 

 

 

Current assets

 

 

 

Debtors

11,038

5,335

1,644

Cash at bank

18,174

20,090

11,807

 

29,212

25,425

13,451

 

 

 

 

Creditors: amounts falling due within one year

(34,357)

(27,427)

(27,321)

 

 

 

 

Net current liabilities

(5,146)

(2,002)

(13,870)

 

 

 

 

Net assets

249,015

269,835

299,010

 

 

 

 

Capital and reserves

 

 

 

Called-up share capital

10,819

10,819

10,819

Special distributable reserve

25,846

25,846

25,846

Share premium account

41,995

41,995

41,995

Merger reserve

61,344

61,344

61,344

Capital redemption reserve

9,421

9,421

9,421

Capital reserve

91,599

111,160

138,013

Revenue reserve

7,991

9,250

11,572

Total shareholders' funds

249,015

269,835

299,010

 

 

 

 

Net asset value per ordinary share (note 5)

1,158.30p

1,255.15p

1,390.86p

 

The accompanying notes are an integral part of the condensed financial statements.

 

 

 

CONDENSED Cash Flow Statement

 

(Unaudited)

Half-year ended

31 March 2020

£'000

 

(Unaudited)

Half-year ended

31 March 2019

£'000

 

(Audited)

Year ended 30 September 2019

£'000

Cash flows from operating activities

 

 

 

Net (loss)/return before taxation

(45,113)

(19,142)

12,661

Add back: finance costs

170

241

433

Losses/(gains) on investments held at fair value through profit or loss

45,235

20,217

(8,166)

Losses/(gains) on foreign exchange

377

(324)

278

Taxation paid

(172)

(316)

(1,228)

Decrease/(increase) in debtors

25

(291)

(6)

(Decrease)/increase in creditors

(565)

400

588

Net cash (outflow)/inflow from operating activities

(43)

785

4,560

Cash flows from investing activities

 

 

 

Sales of investments held at fair value through profit or loss

116,268

109,347

217,431

Purchases of investments held at fair value through profit or loss

(114,808)

(89,741)

(212,242)

Net cash inflow from investing activities

1,460

19,606

5,189

Cash flows from financing activities

 

 

 

Equity dividends paid

(4,665)

(4,622)

(6,686)

Drawdown/(repayment) of bank overdraft

10,147

(29,978)

(24,767)

Interest paid

(155)

(267)

(453)

Net cash inflow/(outflow) from financing activities

5,327

(34,867)

(31,906)

Net increase/(decrease) in cash and cash equivalents

6,744

(14,476)

(22,157)

Cash and cash equivalents at beginning of period

11,807

34,242

34,242

(Losses)/gains foreign exchange

(377)

324

(278)

Cash and cash equivalents at end of period

18,174

20,090

11,807

Comprising:

 

 

 

Cash at bank

18,174

20,090

11,807

     

The accompanying notes are an integral part of these financial statements

 

 

 

Notes to the condensed financial statements

 

1.

Accounting policies

 

The condensed set of financial statements has been prepared in accordance with FRS 104, Interim Financial Reporting, FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland and the Statement of Recommended Practice for "Financial Statements of Investment Trust Companies and Venture Capital Trusts", which was updated by the Association of Investment Companies in October 2019.

 

For the period under review the Company's accounting policies have not varied from those described in the Annual Report for the year ended 30 September 2019. The condensed set of financial statements has been neither audited nor reviewed by the Company's auditor.

 

 

2.

Income from investments

 

 

(Unaudited)

Half-year ended

31 March

2020

£'000

(Unaudited)

Half-year ended

31 March

2019

£'000

 

(Audited)

Year ended

30 September 2019

£'000

Listed investments:

 

 

 

Overseas dividends

1,712

1,901

6,983

UK dividends

107

221

567

 

1,819

2,122

7,550

 

 

 

 

 

3.

Return/(loss) per ordinary share

 

 

(Unaudited)

Half-year ended

31 March 2020

£'000

(Unaudited)

Half-year ended

31 March 2019

£'000

(Audited)

Year ended

30 September 2019

 £'000

The return per ordinary share is based on the following figures:

 

 

 

Net revenue return

1,084

1,381

5,767

Net capital (loss)/return

(46,414)

(20,714)

6,139

Net total (loss)/return

(45,330)

(19,333)

11,906

 

 

 

 

Weighted average number of ordinary shares in issue for each period

21,498,261

21,498,261

21,498,261

 

 

 

 

Revenue return per ordinary share

5.04p

6.42p

26.83p

Capital loss per ordinary share

(215.90p)

(96.35p)

28.55p

Total (loss)/return per ordinary share

(210.86p)

(89.93p)

55.38p

 

The Company has no securities in issue that could dilute the return per ordinary share. Therefore, the basic and diluted returns per share are the same.

 

 

4.

Called-up share capital

 

At 31 March 2020, there were 21,638,991 shares in issue, of which 140,730 are held in treasury, resulting in 21,498,261 shares being entitled to a dividend. During the half-year period ended 31 March 2020, no shares were issued or repurchased (half-year ended 31 March 2019 and year ended 30 September 2019: no shares issued or repurchased). No shares have been issued or repurchased since 31 March 2020.

 

 

5.

Net asset value per ordinary share

 

The net asset value per ordinary share is based on the 21,498,261 ordinary shares in issue at 31 March 2020 (half-year ended 31 March 2019 and year ended 30 September 2019: 21,498,261).

 

 

6.

Management fees

 

Henderson Investment Funds Limited ("HIFL") is appointed to act as the Company's alternative investment fund manager. HIFL delegates investment management services to Henderson Global Investors Limited ("HGIL"). References to Janus Henderson or the Manager within these results refer to the services provided by both HIFL and HGIL.

 

Management fees are charged in accordance with the terms of the management agreement. The Manager receives a fee of 0.65% per annum on the value of the Company's net assets up to £300m and 0.55% on any net assets above £300m calculated quarterly in arrears. In determining the net assets on which the management fee is calculated, the value of any securities held by the Company in collective investment schemes managed by Janus Henderson are excluded.

 

Management fees and finance costs are allocated 25% to revenue and 75% to capital in the Condensed Income Statement.

 

 

7.

Investments held at fair value through profit or loss

 

The table below analyses fair value measurements for investments held at fair value through profit or loss. These fair value measurements are categorised into different levels in the fair value hierarchy based on the valuation techniques used and are defined as follows under FRS 102:

 

Level 1: the unadjusted quoted price in an active market for identical assets or liabilities that the entity can access at the measurement date.

Level 2: inputs other than quoted prices included within Level 1 that are observable (i.e. developed using market data) for the asset or liability, either directly or indirectly.

Level 3: inputs are unobservable (i.e. for which market data is unavailable) for the asset or liability.

 

Financial assets held at fair value through profit or loss at 31 March 2020

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

Quoted equities

254,160

-

-

254,160

Total

254,160

-

-

254,160

 

 

Financial assets held at fair value through profit or loss at 31 March 2019

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

Quoted equities

271,837

-

-

271,837

Total

271,837

-

-

271,837

 

Financial assets held at fair value through profit or loss at 30 September 2019

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

Quoted equities

312,880

-

-

312,880

Total

312,880

-

-

312,880

 

There have been no transfers between levels of fair value hierarchy during the period.

 

 

The valuation techniques used by the Company are explained in the accounting policies note 1(c) in the Company's Annual Report for the year ended 30 September 2019.

 

8.

Borrowings

 

As at 31 March 2020, the Company's bank overdraft included in 'Creditors: amounts falling due within one year' was £33,196,000 (31 March 2019: £17,838,000; 30 September 2019: £23,049,000).

 

 

9.

Going concern

 

The assets of the Company consist of securities that are readily realisable and, accordingly, the directors believe that the Company has adequate resources to continue in operational existence for at least twelve months from the date of approval of these financial statements. This conclusion also takes into account the Board's assessment of the risks arising from COVID-19.

 

10.

Dividends

 

The directors have declared an interim dividend of 9.60p per ordinary share (2019: 9.60p), payable on 26 June 2020 to shareholders on the register on 5 June 2020. The shares will be quoted ex-dividend on 4 June 2020. Based on the 21,498,261 ordinary shares in issue as at 28 May 2020, the cost of this dividend will be £2,064,000 (cost of 2019 interim dividend: £2,064,000).

 

 

11.

Comparative information

 

The financial information contained in this half-year report does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. The financial information for the half-years ended 31 March 2020 and 31 March 2019 has not been audited or reviewed by the Company's auditor. The figures and financial information for the year ended 30 September 2019 are an extract based on the latest published accounts and do not constitute statutory accounts for that year. Those accounts have been delivered to the Registrar of Companies and included the Independent Auditor's Report which was unqualified and did not contain a statement under either s498(2) or s498(3) Companies Act 2006. A glossary of terms and details of alternative performance measures can be found in the Annual Report for the year ended 30 September 2019.

 

 

12.

General information

 

Company status

Henderson European Focus Trust plc is registered in England and Wales (no. 427958), has its registered office at 201 Bishopsgate, London EC2M 3AE and is listed on the London Stock Exchange.

 

SEDOL/ISIN: 0526885/GB0005268858

London Stock Exchange ("TIDM") code: HEFT

Global Intermediary Identification Number ("GIIN"): THMNPN.99999.SL.826

Legal Entity Identifier ("LEI") number: 213800GS89AL1DK3IN50

 

 

Directors and secretary

The directors of the Company are Robert Jeens (Chairman), Eliza Dungworth (Chairman of the Audit Committee), Robin Archibald and Vicky Hastings (Senior Independent Director). The corporate secretary is Henderson Secretarial Services Limited.

 

 

Website

Details of the Company's share price and net asset value, together with general information about the Company, monthly factsheets and data, copies of announcements, reports and details of general meetings can be found at www.hendersoneuropeanfocus.com.

 

 

13.

Half-year report

 

The half-year report will shortly be available on the Company's website or from the Company's registered office. An abbreviated version, the 'Update', will be posted to shareholders in June 2020. The Update will also be posted on the Company's website, and hard copies will be available from the Company's registered office.

 

 

For further information, please contact:

 

James de Sausmarez

Director and Head of Investment Trusts

Henderson Investment Funds Limited

Tel: 020 7818 3349

 

 

Laura Thomas

Investment Trust PR Manager

Janus Henderson Investors

Tel: 020 7818 2636

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) are incorporated into, or form part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR FLFIEEEITFII
Date   Source Headline
3rd May 202412:19 pmRNSNet Asset Value(s)
2nd May 202412:16 pmRNSNet Asset Value(s)
1st May 20241:00 pmRNSNet Asset Value(s)
30th Apr 20241:42 pmRNSNet Asset Value(s)
29th Apr 20244:28 pmRNSNet Asset Value(s)
26th Apr 20241:26 pmRNSNet Asset Value(s)
26th Apr 20247:00 amRNSCompliance with Market Abuse Regulation
25th Apr 202412:29 pmRNSNet Asset Value(s)
24th Apr 202412:32 pmRNSNet Asset Value(s)
23rd Apr 20244:26 pmRNSDoc re. Monthly Factsheet as at 31 March 2024
23rd Apr 202411:46 amRNSNet Asset Value(s)
22nd Apr 20243:37 pmRNSNet Asset Value(s)
19th Apr 202412:33 pmRNSNet Asset Value(s)
18th Apr 20241:07 pmRNSNet Asset Value(s)
17th Apr 202412:02 pmRNSNet Asset Value(s)
16th Apr 202412:01 pmRNSNet Asset Value(s)
15th Apr 20243:49 pmRNSNet Asset Value(s)
12th Apr 202412:28 pmRNSNet Asset Value(s)
11th Apr 202411:56 amRNSNet Asset Value(s)
10th Apr 202412:59 pmRNSNet Asset Value(s)
9th Apr 202412:59 pmRNSNet Asset Value(s)
8th Apr 20242:23 pmRNSNet Asset Value(s)
5th Apr 20241:27 pmRNSNet Asset Value(s)
4th Apr 202411:56 amRNSNet Asset Value(s)
3rd Apr 202412:36 pmRNSNet Asset Value(s)
2nd Apr 20244:09 pmRNSNet Asset Value(s)
28th Mar 20242:52 pmRNSNet Asset Value(s)
27th Mar 202412:55 pmRNSNet Asset Value(s)
26th Mar 202412:03 pmRNSNet Asset Value(s)
25th Mar 20244:20 pmRNSNet Asset Value(s)
22nd Mar 202411:33 amRNSNet Asset Value(s)
21st Mar 20244:34 pmRNSMonthly Factsheet as at 29 February 2024
21st Mar 202412:11 pmRNSNet Asset Value(s)
20th Mar 202411:44 amRNSNet Asset Value(s)
19th Mar 202411:57 amRNSNet Asset Value(s)
18th Mar 20245:02 pmRNSNet Asset Value(s)
15th Mar 202412:16 pmRNSNet Asset Value(s)
14th Mar 20242:00 pmRNSProposed merger of interests of HEFT and HNE
14th Mar 202410:45 amRNSNet Asset Value(s)
13th Mar 202412:42 pmRNSNet Asset Value(s)
12th Mar 20242:02 pmRNSNet Asset Value(s)
11th Mar 20241:45 pmRNSNet Asset Value(s)
8th Mar 202412:05 pmRNSNet Asset Value(s)
7th Mar 202410:18 amRNSNet Asset Value(s)
6th Mar 202411:44 amRNSNet Asset Value(s)
5th Mar 20241:02 pmRNSNet Asset Value(s)
4th Mar 20243:14 pmRNSNet Asset Value(s)
1st Mar 202412:41 pmRNSNet Asset Value(s)
29th Feb 202411:08 amRNSNet Asset Value(s)
28th Feb 202411:27 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.